Skip to main content
. 2018 Apr 16;4(2):00159-2017. doi: 10.1183/23120541.00159-2017

TABLE 4.

Survival data

All patients# No or moderate BD Severe BD+
NIV No NIV p-value NIV No NIV p-value NIV No NIV p-value
Patients 120 20 105 14 15 6
Survival from ALS onset months 43.00 (38.13–47.86) 28.00 (21.40–34.57) 0.001 43.00 (39.01–46.98) 33.00 (26.64–39.35) 0.002 40.00 (29.64–50.35) 16.00 (5.19–26.80) 0.002
Survival from NIV months 18.50 (12.62–24.38) 3.00 (0.82–5.18) 0.001 20.00 (13.71–26.28) 3.00 (0.55–5.44) 0.0001 13.00 (9.49–16.50) 3.00 (0.85–5.14) 0.001

Data are presented as mean (95% CI) unless otherwise stated. NIV: noninvasive ventilation; BD: bulbar dysfunction; ALS: amyotrophic lateral sclerosis. #: n=140; : n=119; +: n=21.